PPH

PPH
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 20.06% | 157.58K | $186.24M |
NVS | Novartis AG | 10.47% | 633.41K | $97.15M |
MRK | Merck & Co., Inc. | 9.56% | 715.80K | $88.78M |
NVO | Novo Nordisk A/S | 5.55% | 1.05M | $51.53M |
BMY | Bristol-Myers Squibb Company | 4.63% | 724.63K | $43.00M |
PFE | Pfizer Inc. | 4.61% | 1.75M | $42.81M |
ABBV | AbbVie Inc. | 4.54% | 169.84K | $42.12M |
MCK | McKesson Corporation | 4.46% | 50.97K | $41.40M |
JNJ | Johnson & Johnson | 4.45% | 160.19K | $41.29M |
GSK | GSK plc | 4.44% | 787.36K | $41.17M |
SNY | Sanofi | 4.16% | 876.86K | $38.58M |
AZN | AstraZeneca PLC | 3.90% | 213.49K | $36.18M |
COR | Cencora, Inc. | 3.65% | 110.80K | $33.92M |
HLN | Haleon plc | 3.29% | 3.09M | $30.52M |
TAK | Takeda Pharmaceutical Company Limited | 2.97% | 1.67M | $27.60M |
TEVA | Teva Pharmaceutical Industries Limited | 2.92% | 843.24K | $27.14M |
ZTS | Zoetis Inc. | 2.22% | 272.85K | $20.57M |
VTRS | Viatris Inc. | 1.14% | 644.23K | $10.56M |
JAZZ | Jazz Pharmaceuticals plc | 1.07% | 41.90K | $9.93M |
AXSM | Axsome Therapeutics, Inc. | 0.72% | 29.30K | $6.69M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
NVS
Novartis AG
MRK
Merck & Co., Inc.
NVO
Novo Nordisk A/S
BMY
Bristol-Myers Squibb Company
PFE
Pfizer Inc.
ABBV
AbbVie Inc.
MCK
McKesson Corporation
JNJ
Johnson & Johnson
GSK
GSK plc
SNY
Sanofi
AZN
AstraZeneca PLC
COR
Cencora, Inc.
HLN
Haleon plc
TAK
Takeda Pharmaceutical Company Limited
TEVA
Teva Pharmaceutical Industries Limited
ZTS
Zoetis Inc.
VTRS
Viatris Inc.
JAZZ
Jazz Pharmaceuticals plc
AXSM
Axsome Therapeutics, Inc.
